🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary purpose of this phase II clinical trial is to determine the saf...
Status
Completed
Location
Jonsson Comprehensive Cancer Center
Start Date
2012-01-10
Trial ID
NCT01635283
Treatments Being Tested
This study is open to women with recurrent epithelial ovarian carcinoma or ...
Status
Completed
Location
University of Pennsylvania
Start Date
2007-11
Trial ID
NCT00683241
Treatments Being Tested
The purpose of this study is to determine if a dendritic cell vaccine made ...
Status
Unknown
Location
Loyola Univeristy Medical Center, Cardinal Bernardin Cancer Center
Start Date
2008-10
Trial ID
NCT00703105
Treatments Being Tested
Single center, phase I/II randomized 2-arm study, evaluating two different ...
Status
Withdrawn
Location
Multiple Locations
Start Date
2023-08-01
Trial ID
NCT05714306
Treatments Being Tested
The aim of the study is to show if vaccination with autologous dendritic ce...
Status
Completed
Location
Department of Oncology, Copenhagen University Hospital, Herlev
Start Date
2004-09
Trial ID
NCT00197912
Treatments Being Tested
RATIONALE: Vaccines made from a person's white blood cells mixed with tumor...
Status
Completed
Location
Jonsson Comprehensive Cancer Center at UCLA
Start Date
2003-06
Trial ID
NCT00068510
Treatments Being Tested
This phase I/II trials evaluates the feasibility, safety and efficacy of an...
Status
Completed
Location
University Children's Hospital
Start Date
2018-02-07
Trial ID
NCT03879512
Treatments Being Tested
The goal of this clinical trial is to learn if DOC1021 + pIFN will be safe ...
Status
Recruiting
Location
The University of Alabama at Birmingham
Start Date
2026-04-06
Trial ID
NCT07288112
Treatments Being Tested
1. Primary outcome measure: a.Evaluation of the treatment impact on pro...
Status
Completed
Location
Clínica Universidad de Navarra
Start Date
2009-10
Trial ID
NCT01006044
Treatments Being Tested
This phase II, randomized, open-label trial aims to assess whether the vacc...
Status
Terminated
Location
UO Immunoterapia e laboratorio TCS, IRST IRCCS
Start Date
2015-08
Trial ID
NCT02718391
Treatments Being Tested